Clinical effect of tumor spread through air spaces on prognosis in non-small cell lung cancer: A systematic review and meta-analysis
- VernacularTitle:气腔播散对非小细胞肺癌预后水平影响的系统评价与 Meta 分析
- Author:
Cong LIU
1
;
Yuanrui JIANG
2
;
Naiquan MAO
3
;
Shoufeng WANG
3
;
Liufu SU
3
Author Information
1. Graduate School of Guangxi Medical University, Nanning, 530021, P. R. China
2. Graduate School of Guangxi University of Chinese Medicine, Nanning, 530022, P. R. China
3. Department of Thoracic Surgery, Guangxi Tumor Hospital, Nanning, 530021, P. R. China
- Publication Type:Journal Article
- Keywords:
Spread through air spaces;
non-small cell lung cancer;
surgical treatment;
prognosis;
systematic review/meta-analysis
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2022;29(05):642-650
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the potential role of tumor spread through air spaces (STAS) as a prognostic indicator of non-small cell lung cancer (NSCLC) through meta-analysis. Methods PubMed, EMbase and Web of Science, from inception to February 2022 were searched by computer about the research of the 5-year overall survival (OS) and recurrence free survival (RFS) of NSCLC patients with or without STAS. The Newcastle-Ottawa scale (NOS) was used to evaluate the quality of each study. Results Totally 13 published articles were included with 4 647 patients, and 1 424 (30.6%) patients had STAS. The NOS score of all studies≥6 points. The meta-analysis showed that compared with the NSCLC patients without STAS, those with STAS had a worse prognosis of 5-year RFS, and the combined HR was 1.89 (95%CI 1.61-2.23); they had a shorter 5-year OS, and the combined HR was 2.25 (95%CI 1.79-2.84). There was no statistical heterogeneity among studies. Conclusion The presence of STAS may be a poor prognostic factor for patients with NSCLC, and enough attention should be paid. The STAS should be recorded in the pathological report to guide the comprehensive treatment and evaluate the prognosis of patients.
